COLLCollegium Pharmaceutical, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 13634
Ticker: COLL
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2015-05-07
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: COLL

Detail

Enriched 2026-08-14 20:47

Market cap: $833,548,120.3
Shares outstanding (class): 32,555,613
Shares outstanding (weighted): 32,433,779
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 423
Location: STOUGHTON, MA
Homepage: https://www.collegiumpharma.com
Description: Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Market cap and share counts drift.

Funds holding this security

155 funds · 156 positions · $382.25M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Core S&P Small-Cap ETF iShares Trust	IJR	$62.71M	0.07%	1,896,132 NS	FIGI
FULLERTHALER BEHAVIORAL SMALL CAP EQUITY Capitol Series Trust	—	$47.31M	0.42%	1,430,708 NS	FIGI
Eventide Gilead Fund MUTUAL FUND SERIES TRUST	—	$44.46M	1.66%	1,344,376 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$31.37M	0.00%	948,657 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$25.37M	0.04%	767,132 NS	FIGI
Invesco Main Street Small Cap Fund AIM Growth Series (Invesco Growth Series)	—	$11.69M	0.53%	353,371 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$11.67M	0.01%	352,979 NS	FIGI
State Street(R) SPDR(R) Portfolio S&P 600(TM) S… SPDR SERIES TRUST	SPSM	$9.56M	0.07%	288,950 NS	FIGI
iShares S&P Small-Cap 600 Growth ETF iShares Trust	IJT	$9.02M	0.14%	272,773 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$8.44M	0.07%	255,137 NS	FIGI
VANGUARD TAX-MANAGED SMALL-CAP FUND VANGUARD TAX-MANAGED FUNDS	—	$7.43M	0.08%	224,654 NS	FIGI
MFS New Discovery Series MFS VARIABLE INSURANCE TRUST	—	$6.98M	0.99%	211,180 NS	FIGI
Invesco V.I. Main Street Small Cap Fund AIM Variable Insurance Funds (Invesco Varia…	—	$6.17M	0.53%	186,689 NS	FIGI
State Street(R) SPDR(R) S & P 600(TM) Small Cap… SPDR SERIES TRUST	SLYG	$5.51M	0.14%	166,751 NS	FIGI
Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust	—	$5.48M	0.06%	165,772 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERCOLL
FIGI_COMPOSITEBBG000N7LPW4
FIGI_SHARE_CLASSBBG001T535S9
CIK0001267565
ISINUS19459J1043
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Collegium Pharmaceutical is a biopharmaceutical company focused on pain management, classified under pharmaceuticals.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.